Skip to main content
OpenTrials
Completed

NCT Number: NCT04288791

Evaluation of the Clinical Performance of Reinforced Glass Ionomer Restorations

This study is conducted to evaluate the clinical performance of class I reinforced glass ionomer restorations (Zirconomer Improved and Equia Forte Fil)

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dental Caries Stomatognathic Diseases Tooth Demineralization Tooth Diseases

Age range

20 year–47 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Al-Azhar University, Faculty of Dentistry For Girls

Cairo, Egypt

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Normal occlusal relation with normal dentition.
  • Absence of pain from the tooth to be restored.
  • Absence of any active periodontal and pulpal diseases from the tooth to be restored.
  • Medium-sized (buccolingually and mesio-distally) occlusal carious lesions extending into dentin.

Exclusion criteria

  • Patients with a history of tooth sensitivity.
  • Patients with bruxism.
  • Defective restorations adjacent or opposing to the tooth.
  • Abutment teeth used for fixed or removable prosthesis.
  • Patients who refused to sign the consent form.
  • Inability to return to recall appointments

Treatment and study plan

Equia Forte Fil

Other

Glass hybrid innovation achieved through the introduction of ultrafine, highly reactive glass particles dispersed with conventional GI. The restoration is coated with Equia Forte coat which incorporates multi-functional monomer producing a tougher resin matrix. This system is designed as alternative of amalgam in posterior teeth.

Zirconomer Improved

Other

Zirconia reinforced GI, Glass Polyalkenoate restoration; it is designed to exhibit high strength where the glass component of this GI undergoes finely controlled micronization to achieve optimum particle size and characteristics .

Primary outcomes

  1. Clinical Performance of the restoration

    Time frame: 6 months

    Success Rate

Sponsors and collaborators

Lead sponsor

Al-Azhar University

Other

Registry information

Important dates

Study start
2018
Primary completion
2018
Study completion
2019
First posted
Feb 28, 2020
Registry last updated
Mar 17, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.